Designed to enable efficient scalability, a new FBR platform allows operators to use one technology, with a standardized workflow, for their process development, scale-up, and manufacturing processes.

Multi-well inserts allowing for a two-chamber system that can expose cell cultures from above and below can provide greater versatility and expand research options compared to many standard cell culture plates.

Understand the critical considerations for implementing closed systems in bioproduction, from vessel selection to workflow customization for optimal efficiency and safety.

Growth factors in cell culture media are essential for cell survival and behavior. Uncover their diverse roles and the science behind choosing the right ones.

Cell culture media quality is key for lab success. Learn essential sourcing, storage, and handling strategies to prevent contamination and costly setbacks.

Keep your cells thriving. Learn the essential cell culture media change protocol, including frequency, steps, and tips for optimal cell growth. Discover best practices and avoid common pitfalls.

Struggling with reproducible cell culture results? Sera variability is a major culprit. Learn how to choose the right sera, test lots, and stock up to ensure consistency and boost reproducibility.

A fetal bovine serum shortage would have significant repercussions throughout the life sciences industry. However, there are a few steps FBS users can take now to secure their supply chain.

Learn how to enhance your projects and support high-density cell cultures using a closed system or closed loop system to minimize contamination and improve safety.

This study evaluates the performance of a flexible, automated fixed bed reactor (FBR) system during AAV production, comparing it with a similar FBR system and 2D cell culture controls.

The Corning CellCube system enables large-scale adherent cell culture with uniform laminar flow, optimizing growth. Its closed system design ensures aseptic scalability with AseptiQuick® connectors.

Corning offers standard and custom cell culture media, vessels, and surfaces to support all growth stages. A vertically integrated supply chain ensures reliability and quality.

Ensure uninterrupted cell culture success with reliable, high-quality animal-derived serum, including FBS, with consistent performance. Learn how to secure your supply.

As part of our complete cell culture offering, Corning’s comprehensive line of standard and custom cell culture media helps create an optimal environment for all stages of cell culture growth and scaling.

Corning Closed System solutions for CellSTACK vessels streamline the cell culture process while reducing the risk of contamination.

During each Cell & Gene Live, our audience can submit real-time questions for our expert panelists. Watch and listen as Michael Blackton and John Lee provide detailed, insightful responses to our audience questions on everything from how changing from a lab-based adherent protocol to suspension scalable protocol improved the cell product to whether a container with lesser cells, identical cell density, and composition be used for establishing stability for cell therapy products, and much more.

During Cell & Gene Live, "Scaling Cell Therapies Part 2: Establishing Comparability in Manufacturing," Michael Blackton and John Lee provided detail on how successful comparability studies are designed and executed. They covered the in-process and release testing requirements, as well as the common and uncommon pit falls that have been encountered.

For cell-based products, donor-to-donor variability is the primary source of complexity associated with establishing product comparability. In this segment of Cell & Gene Live, "Scaling Cell Therapies Part 2: Establishing Comparability in Manufacturing," Michael Blackton and John Lee cover why donor-to-donor variability is an on-going challenge and potential solutions.

Here, during this segment of Cell & Gene Live, "Scaling Cell Therapies Part 2: Establishing Comparability in Manufacturing," Michael Blackton and John Lee highlight the various ways to demonstrate our understanding of how the process influences the product, as well as how the product’s structure influences its clinical function.

As a therapy proceeds through Phases I / II and into Phase III clinical trials, the comparability burden increases. As the body of knowledge increases, the comparability burden evolves. Some tests may be removed while others are added, and assumptions may change with data. In this segment of Cell & Gene Live, "Scaling Cell Therapies Part 2: Establishing Comparability in Manufacturing," Michael Blackton and John Lee break down the comparability requirements from early- to late-stage programs.

During this Cell & Gene Live, "Scaling Cell Therapies Part 2: Establishing Comparability in Manufacturing," Cell & Gene's Chief Editor, Erin Harris, Michael Blackton, former SVP Cell Therapy Manufacturing at Nurix Therapeutics, and John Lee, SVP, Head of Cell Therapy at Center for Breakthrough Medicines, talk through the CGT sector's greatest struggles with comparability. Indeed in this segment, Blackton and Lee cover the sector's biggest challenges to date from the need to truly understand the product to precise analytics and eliminating silos, and more.

In this video our application scientists walk you through common research goals and the most suitable 3D cell culture solutions for each.

There are many harvesting options depending on the cell line and application. In this video we discuss some tips and tricks for harvesting cells.

The Corning® Matribot® bioprinter uses a revolutionary cooling syringe printhead technology that allows you to dispense 3D droplets or droplet arrays for organoid applications.

With gas-permeable film, this closed system offers more surface area within a compact footprint. Watch this short video to learn more.

We visit the MEARY Center to see how they produce new cells and new gene therapy drugs to treat patients suffering from autoimmune, hematological, and cardiac diseases, and so much more.

In the complex world of cell and gene therapy, having a seasoned partner to guide you through uncharted production territory is critical to success.

Corning’s Field Applications Specialists work with scientists like you to overcome complex manufacturing challenges and streamline the path to production.

The Ascent FBR System’s novel mesh substrate intensifies cell growth surface area to produce high cell yields more efficiently.

When you need a reliable path from research to bioprocessing try efficient tools like the Corning® HYPERFlask® cell culture vessel.